These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 317079)

  • 1. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
    Feltham S; Ronald AR; Albritton WL
    J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.
    Biddle JW; Thornsberry C
    Antimicrob Agents Chemother; 1979 Feb; 15(2):243-5. PubMed ID: 106776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
    Santoro J; Kaye D; Levison ME
    Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
    Aldridge KE; Cammarata C; Martin DH
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
    Kwok YY; Sutter VL; Oberhammer I; Finegold SM
    J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
    [No Abstract]   [Full Text] [Related]  

  • 6. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
    Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
    J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the in vitro activity of rosamicin, erythromycin, spiramycin, penicillin and tetracycline against N. gonorrhoeae, including beta-lactamase producing isolates.
    Dillon JR; Duck PD; Eidus L
    J Antimicrob Chemother; 1978 Sep; 4(5):477-80. PubMed ID: 99424
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
    Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
    Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
    Shadomy S; Tipple M; Paxton L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
    Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
    Madinier IM; Fosse TB; Hitzig C; Charbit Y; Hannoun LR
    J Periodontol; 1999 Aug; 70(8):888-92. PubMed ID: 10476896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.
    Levison ME; Santoro J; Bran JL; Ries K; Rubin W
    J Infect Dis; 1977 Mar; 135 Suppl():S49-53. PubMed ID: 850091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Haemophilus ducreyi. A study.
    Sng EH; Lim AL; Rajan VS; Goh AJ
    Br J Vener Dis; 1982 Aug; 58(4):239-42. PubMed ID: 6980682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance of Haemophilus ducreyi.
    Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
    Sturm AW
    J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
    Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
    Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
    DiPersio JR; Krafczyk TL
    Antimicrob Agents Chemother; 1978 Aug; 14(2):274-6. PubMed ID: 697353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Haemophilus ducreyi.
    Hammond GW; Lian CJ; Wilt JC; Ronald AR
    Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
    Lagergård T; Frisk A; Trollfors B
    J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.